[Federal Register Volume 84, Number 204 (Tuesday, October 22, 2019)]
[Notices]
[Pages 56459-56460]
[FR Doc No: 2019-23014]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-4466]

Determination That PROAMATINE (Midodrine Hydrochloride) Tablets,
2.5 Milligrams, 5 Milligrams, and 10 Milligrams, Were Not Withdrawn
From Sale for Reasons of Safety or Effectiveness

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) has
determined that PROAMATINE (midodrine hydrochloride) tablets, 2.5
milligrams (mg), 5 mg, and 10 mg, were not withdrawn from sale for
reasons of safety or effectiveness. This determination allows FDA to
approve abbreviated new drug applications (ANDAs) for midodrine
hydrochloride tablets, 2.5 mg, 5 mg, and 10 mg, if all other legal and
regulatory requirements are met.

FOR FURTHER INFORMATION CONTACT: Kristiana Brugger, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6262, Silver Spring, MD 20993-0002, 301-
796-3601.

SUPPLEMENTARY INFORMATION: In 1984, Congress enacted the Drug Price
Competition and Patent Term Restoration Act of 1984 (Pub. L. 98-417)
(the 1984 amendments), which authorized the approval of duplicate
versions of drug products under an ANDA procedure. ANDA applicants
must, with certain exceptions, show that the drug for which they are
seeking approval contains the same active ingredient in the same
strength and dosage form as the ``listed drug,'' which is a version of
the drug that was previously approved. ANDA applicants do not have to
repeat the extensive clinical testing otherwise necessary to gain
approval of a new drug application (NDA).
    The 1984 amendments include what is now section 505(j)(7)(A) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)(7)(A)), which
requires FDA to publish a list of all approved drugs. FDA publishes
this list as part of the ``Approved Drug Products With Therapeutic
Equivalence Evaluations,'' which is known generally as the ``Orange
Book.'' Under FDA regulations, drugs are removed from the list if the
Agency withdraws or suspends approval of the drug's NDA or ANDA for
reasons of safety or effectiveness or if FDA determines that the listed
drug was withdrawn from sale for reasons of safety or effectiveness (21
CFR 314.162).
    A person may petition the Agency to determine, or the Agency may
determine on its own initiative, whether a listed drug was withdrawn
from sale for reasons of safety or effectiveness.
    PROAMATINE (midodrine hydrochloride) tablets, 2.5 mg, 5 mg, and 10
mg, is the subject of NDA 019815, held by Shire Development LLC
(Shire), and initially approved on September 6, 1996, under the
accelerated approval process (see 21

CFR 314.510). PROAMATINE is indicated for the treatment of orthostatic
hypotension. PROAMATINE (midodrine hydrochloride) tablets, 2.5 mg, 5
mg, and 10 mg, is currently listed in the ``Discontinued Drug Product
List'' section of the Orange Book. Shire no longer markets PROAMATINE
in any strength; although there are approved ANDAs referencing NDA
019815, PROAMATINE has been withdrawn from sale.
    We have carefully reviewed our files for records concerning the
withdrawal of PROAMATINE (midodrine hydrochloride) tablets, 2.5 mg, 5
mg, and 10 mg, from sale. We have also independently evaluated relevant
literature and data for possible postmarketing adverse events. FDA has
determined under Sec.  314.161 that PROAMATINE (midodrine
hydrochloride) tablets, 2.5 mg, 5 mg, and 10 mg, were not withdrawn
from sale for reasons of safety or effectiveness.
    Accordingly, FDA will continue to list PROAMATINE (midodrine
hydrochloride) tablets, 2.5 mg, 5 mg, and 10 mg, in the ``Discontinued
Drug Product List'' section of the Orange Book. We note that, because
PROAMATINE (midodrine hydrochloride) tablets, 2.5 mg, 5 mg, and 10 mg,
were approved under the accelerated approval pathway, Shire was
required to conduct post-approval studies to verify the clinical
benefit of PROAMATINE (midodrine hydrochloride) tablets, 2.5 mg, 5 mg,
and 10 mg. The clinical benefit of PROAMATINE (midodrine hydrochloride)
tablets, 2.5 mg, 5 mg, and 10 mg, remains subject to verification.
    ANDAs that refer to PROAMATINE (midodrine hydrochloride) tablets,
2.5 mg, 5 mg, and 10 mg, may be approved by the Agency as long as they
meet all other legal and regulatory requirements for the approval of
ANDAs. If FDA determines that labeling for this drug product should be
revised to meet current standards, the Agency will advise ANDA
applicants to submit such labeling.

    Dated: October 15, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-23014 Filed 10-21-19; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 78, Number 232 (Tuesday, December 3, 2013)]
[Notices]
[Pages 72669-72670]
[FR Doc No: 2013-28798]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC14-32-000.
    Applicants: Noble Americas Gas & Power Corp., Eagle Point Power
Generation LLC.
    Description: Application for approval Pursuant to Section 203 of
the Federal Power Act, request for expedited consideration and request
for privileged treatment re Noble Americas Gas & Power Corp et al.
    Filed Date: 11/19/13.
    Accession Number: 20131120-0001.
    Comments Due: 5 p.m. ET 12/10/13

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-1674-003.
    Applicants: Deseret Generation & Transmission Co-operative, Inc.
    Description: Deseret Generation & Transmission Co-operative, Inc's
Amendment to the July 2, 2013 Updated Market Power Analysis.
    Filed Date: 11/20/13.
    Accession Number: 20131120-5153.
    Comments Due: 5 p.m. ET 12/11/13.

    Docket Numbers: ER11-1858-002; ER11-1859-001.
    Applicants: NorthWestern Corporation.
    Description: Supplement to July 1, 2013 NorthWestern Corporation,
et. al.'s updated market power screen analysis for wholesale
electricity markets in the Northwest Region.
    Filed Date: 11/20/13.
    Accession Number: 20131120-5027.
    Comments Due: 5 p.m. ET 12/11/13.

    Docket Numbers: ER11-3697-005.
    Applicants: Southern California Edison Company.
    Description: Southern California Edison Company submits ETC Refund
Report to be effective N/A.
    Filed Date: 11/21/13.
    Accession Number: 20131121-5003.
    Comments Due: 5 p.m. ET 12/12/13.

    Docket Numbers: ER14-16-000.
    Applicants: Burgess Biopower LLC.
    Description: Errata to October 2, 2013 Burgess Biopower LLC tariff
filing.
    Filed Date: 11/7/13.
    Accession Number: 20131107-5123.
    Comments Due: 5 p.m. ET 12/5/13.

    Docket Numbers: ER14-437-000.
    Applicants: Puget Sound Energy, Inc.
    Description: Reassignment Tariff Revisions to be effective 6/30/
2013.

    Filed Date: 11/20/13.
    Accession Number: 20131120-5082.
    Comments Due: 5 p.m. ET 12/11/13.

    Docket Numbers: ER14-438-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Southwest Power Pool, Inc. submits 2198R13 Kansas
Power Pool NITSA and NOA to be effective 11/1/2013.
    Filed Date: 11/20/13.
    Accession Number: 20131120-5102.
    Comments Due: 5 p.m. ET 12/11/13.

    Docket Numbers: ER14-439-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: PJM Interconnection, L.L.C. submits Notice of
Cancellation of Original Service Agreement No. 3343; Queue No. X1-005
to be effective 11/18/2013.
    Filed Date: 11/20/13.
    Accession Number: 20131120-5127.
    Comments Due: 5 p.m. ET 12/11/13.

    Docket Numbers: ER14-440-000.
    Applicants: Southern California Edison Company.
    Description: Southern California Edison Company submits Fully
Executed GIA and Distribution Service Agmt with Rhodia Inc to be
effective 11/22/2013.
    Filed Date: 11/21/13.
    Accession Number: 20131121-5001.
    Comments Due: 5 p.m. ET 12/12/13.

    Docket Numbers: ER14-441-000.
    Applicants: Southern California Edison Company.
    Description: Southern California Edison Company submits SGIA and
Distribution Service Agreement with SEPV Palmdale East, LLC to be
effective 11/22/2013.
    Filed Date: 11/21/13.
    Accession Number: 20131121-5002.
    Comments Due: 5 p.m. ET 12/12/13.

    Docket Numbers: ER14-442-000.
    Applicants: Brookfield Energy Marketing LP.
    Description: Petition of Brookfield Energy Marketing LP for Limited
Waiver.
    Filed Date: 11/21/13.
    Accession Number: 20131121-5047.
    Comments Due: 5 p.m. ET 12/12/13.

    Docket Numbers: ER14-443-000.
    Applicants: Southern California Edison Company.
    Description: Southern California Edison Company submits tariff
filing per 35.13(a)(2)(iii: GIAs and Distribution Service Agmts with
Kona Solar LLC to be effective 11/22/2013.
    Filed Date: 11/21/13.
    Accession Number: 20131121-5094.
    Comments Due: 5 p.m. ET 12/12/13.

    Docket Numbers: ER14-444-000.
    Applicants: New York Independent System Operator, Inc., Niagara
Mohawk Power Corporation.
    Description: New York Independent System Operator, Inc. submits
Cost Reimbursement Agreement No. 2056 Between NYSEG and Niagara Mohawk
to be effective 10/1/2013.
    Filed Date: 11/21/13.
    Accession Number: 20131121-5138.
    Comments Due: 5 p.m. ET 12/12/13.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES14-11-000.
    Applicants: Southern Power Company.
    Description: Application of Southern Power Company for
authorization to issue securities under Section 204 of the Federal
Power Act and request for exemption from competitive bidding
requirements.
    Filed Date: 11/21/13.
    Accession Number: 20131121-5118.
    Comments Due: 5 p.m. ET 12/12/13.

    Docket Numbers: ES14-12-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Application of Southwest Power Pool, Inc. Under
Section 204 of the Federal Power Act for an Order Authorizing the
Issuance of Securities.
    Filed Date: 11/21/13.
    Accession Number: 20131121-5120.
    Comments Due: 5 p.m. ET 12/12/13.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: November 21, 2013.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2013-28798 Filed 12-2-13; 8:45 am]
BILLING CODE 6717-01-P


RMB Consulting & Research, Inc. 5104 Bur Oak Circle 																																							Phone<PHONE_NUMBER> Raleigh, North Carolina 27612																																Fax<PHONE_NUMBER>

T E C H N I C A L  M E M O R A N D U M

TO:	Michalene Reilly, Hoosier Energy 	Jay Holloway, Sutherland Asbill & Brennan LLP 		 FROM:	Ralph Roberson, RMB 	Rob Barton, RMB 		  DATE:	March 17, 2015

SUBJECT:			Supporting Analysis for Hoosier Alternative to Proposed Clean Power Plan

The following memo summarizes the methodology used to determine the emissions reduction associated with Hoosier Energy's proposed alternative to EPA's proposed Clean Power Plan (CPP).

This memo focuses on the procedures used to estimate the emissions reduction in 2030 and compares this reduction with EPA's estimate in the proposed CPP.  RMB assumed that all units that commenced commercial operation prior to 1978 would be retired by 2030 and all units that commenced operation after 1978 would remain in operation.

METHODOLOGY

   (1) Determination of Coal-Fired Emissions Database  RMB created a new CO2 emissions database that contained annual average emissions data for all coal-fired units for the period 2003  -  2012.  The database was similar to the EPA database used in the CPP rulemaking although it was comprised solely of data from the Clean Air Markets Division (CAMD) quarterly emissions files and included dates of commercial operation and CO2 emissions estimates (tons per year and lb/MWhg) based on gross generation.  In RMB's database, all CO2 emissions averages excluded substituted data and bias adjustment factors.  RMB used gross generation data rather than net generation data to avoid the use of EIA net generation data, which was found to contain reporting errors that resulted in anomalous CO2 emissions rates in the EPA database.  Although net and gross generation may differ 5-10 percent depending on the plant, these differences are not relevant for this analysis because both RMB and EPA estimated mass reduction using a consistent basis (e.g. mass reduction = gross generation (MWhg) x CO2 emission rate (lb/MWhg) = net generation (MWhn) x CO2 emission rate (lb/MWhn).

   (2) Calculate 2030 Baseline Emissions for All Coal-Fired Units RMB calculated baseline emissions for 2030 for all coal-fired units in the fleet.  This estimate is based on unit-specific capacity factors, unit generator ratings, and historical CO2 emissions rates (lb/MWhg).  The 2030 capacity factor for each unit is based on the average capacity factor for the period 2003  -  2012.  This assumption was based on "business as usual" where historical operation is representative of future operation.  The CO2 emission rate is based on the average emissions rate (lb/MWhg) for the period 2003  -  2012.  For any unit that was missing the average CO2 emission rate or capacity factor, the average value was applied for all units for the period 2003  -  2012.  RMB assumed that any unit that operated at any point during the 2003  -  2012 timeframe would continue operating until 2030 (e.g. no unit shutdowns prior to 2030  -  all reductions would occur in the year 2030).  No new coal-fired generation is assumed for the period 2012  -  2030.  Any new generation that is required during that time would be provided by other sources (i.e. gas, renewable energy, nuclear) and/or demand-side reductions.

   (3) Estimate Emissions Reduction Due to Unit Heat Rate Improvements RMB estimated the emissions reductions associated with the proposed heat rate improvements for all coal-fired units in the fleet.   RMB assumed an average heat rate improvement for all units of 2 percent.  Because changes in heat rate correlate directly with CO2 emissions rate, RMB reduced the annual average CO2 emissions rates by the same percentage as the estimated heat rate improvement.  The estimated emissions reductions were then calculated for those units that commenced commercial operation before and after 1978 using different methodologies.  For those units that commenced commercial operation prior to 1978, the effects of the heat rate improvements were included in the estimated emissions reductions associated with the shutdown of these units in 2030 as described below.  For those units that commenced commercial operation after 1978, the estimated emissions reductions were calculated by comparing the heat-rate adjusted emissions to the baseline emissions for the affected units.

   (4) Estimate 2030 Emissions Reductions Including Natural Gas Offset RMB assumed that the lost generation due to shut down of pre-1978 units was replaced with 100 percent gas-fired generation.  This scenario assumes that the required gas generation would be achieved by increasing the capacity of existing gas-fired units and by the construction of new combined cycle units.  The CO2 emissions rate was assumed to be equivalent to a new combined cycle unit (1,000 lb /MWhg).

RESULTS

The results show an estimated annual emissions reduction in 2030 of 750 million tons of CO2 with natural gas offset.  These estimates provide a range of estimated reductions associated with the proposal.  Actual reductions will be somewhere between these two estimates because replacement generation will include a combination of gas-fired and non-fossil fuel generation.  These results compare with EPA's estimated emissions reduction of 600 million tons of CO2 for Compliance Option #1 using the regional compliance approach and 612 million tons using the state-level compliance approach.


[Federal Register Volume 84, Number 197 (Thursday, October 10, 2019)]
[Notices]
[Pages 54714-54715]
[FR Doc No: 2019-22140]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-87230; File No. SR-NASDAQ-2019-061]

Self-Regulatory Organizations; The Nasdaq Stock Market LLC;
Notice of Designation of a Longer Period for Commission Action on a
Proposed Rule Change Relating to the Nasdaq Official Closing Price for
Nasdaq-Listed Exchange-Traded Products

October 4, 2019.
    On August 8, 2019, The Nasdaq Stock Market LLC (``Nasdaq'') filed
with the Securities and Exchange Commission (``Commission''), pursuant
to Section 19(b)(1) of the Securities Exchange Act of 1934 (``Act'')
\1\ and Rule 19b-4 thereunder,\2\ a proposed rule change relating to
how the Nasdaq Official Closing Price will be determined for a Nasdaq-
listed security that is an exchange-traded product. The proposed rule
change was published for comment in the Federal Register on August 23,
2019.\3\ The Commission has received no comments on the proposed rule
change.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ See Securities Exchange Act Release No. 86705 (August 19,
2019), 84 FR 44343.
---------------------------------------------------------------------------

    Section 19(b)(2) of the Act \4\ provides that within 45 days of the
publication of notice of the filing of a proposed rule change, or
within such longer period up to 90 days as the Commission may designate
if it finds such longer period to be appropriate and publishes its
reasons for so finding, or as to which the self-regulatory organization
consents, the Commission shall either approve the proposed rule change,
disapprove the proposed rule change, or institute proceedings to
determine whether the proposed rule change should be disapproved. The
45th day after publication of the notice for this proposed rule change
is October 7, 2019. The Commission is extending this 45-day time
period.
---------------------------------------------------------------------------

    \4\ 15 U.S.C. 78s(b)(2).
---------------------------------------------------------------------------

    The Commission finds it appropriate to designate a longer period
within which to take action on the proposed rule change so that it has
sufficient time to consider the proposed rule change. Accordingly, the
Commission, pursuant to Section 19(b)(2) of the Act,\5\ designates
November 21, 2019, as the date by which the Commission shall either
approve or disapprove, or institute proceedings to determine whether to
disapprove, the proposed

rule change (File No. SR-NASDAQ-2019-061).
---------------------------------------------------------------------------

    \5\ Id.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\6\
---------------------------------------------------------------------------

    \6\ 17 CFR 200.30-3(a)(31).
---------------------------------------------------------------------------

Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2019-22140 Filed 10-9-19; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 84, Number 90 (Thursday, May 9, 2019)]
[Proposed Rules]
[Page 20318]
[FR Doc No: C1-2019-07192]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 165

[Docket No. USCG-2018-1057]
RIN 1625-AA00

Extension of Comment Period for the Safety Zone; Gastineau
Channel, Juneau, AK

Correction

    Proposed rule document 2019-07192 appearing on pages 14663-14664 in
the issue of April 11, 2019 was inadvertently published in the Notice
section.
    (1) The document should have appeared in the Proposed Rule section.
    (2) On page 14663, in the third column, the heading is corrected to
read as set forth above.

[FR Doc. C1-2019-07192 Filed 5-8-19; 8:45 am]
 BILLING CODE 1301-00-D


[Federal Register: February 24, 2010 (Volume 75, Number 36)]
[Notices]
[Page 8340-8341]
[DOCID:fr24fe10-76]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2009-0777; FRL-8813-9]

Maneb; Product Cancellation Order of a Certain Pesticide
Registration

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's order for the cancellation,
voluntarily requested by the registrant and accepted by the Agency, of
a product containing the pesticide maneb, pursuant to section 6(f)(1)
of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as
amended. This cancellation order follows a January 6, 2010 Federal
Register Notice of Receipt of Request from the registrant, Drexel
Chemical Company, to voluntarily cancel their product registration.
This is not the last product containing this pesticide registered for
use in the United States. In the January 6, 2010 notice, EPA indicated
that it would issue an order implementing the cancellation, unless the
Agency received substantive comments within the 30-day comment period
that would merit its further review of these requests, or unless the
registrant withdrew their request within this period. The Agency did
not receive any comments on the notice. Further, the registrant did not
withdraw their request. Accordingly, EPA hereby issues in this notice a
cancellation order granting the requested cancellation. Any
distribution, sale, or use of the product subject to this cancellation
order is permitted only in accordance with the terms of this order,
including any existing stocks provisions.

DATES: The cancellation is effective February 24, 2010.

FOR FURTHER INFORMATION CONTACT: Barbara Briscoe, Pesticide Re-
evaluation Division (7508P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001; telephone number:<PHONE_NUMBER>; fax
number:<PHONE_NUMBER>; e-mail address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    This action is directed to the public in general, and may be of
interest to a wide range of stakeholders including environmental, human
health, and agricultural advocates; the chemical industry; pesticide
users; and members of the public interested in the sale, distribution,
or use of pesticides. Since others also may be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action. If you have any questions regarding the
applicability of this action to a particular entity, consult the person
listed under FOR FURTHER INFORMATION CONTACT.

B. How Can I Get Copies of this Document and Other Related Information?

    EPA has established a docket for this action under docket
identification (ID) number EPA-HQ-OPP-2009-0777. Publicly available
docket materials are available either in the electronic docket at
http://www.regulations.gov, or, if only available in hard copy, at the
Office of Pesticide Programs (OPP) Regulatory

Public Docket in Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. The hours of operation of this Docket
Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding
legal holidays. The Docket Facility telephone number is<PHONE_NUMBER>.

II. What Action is the Agency Taking?

    This notice announces the cancellation, as requested by registrant,
of a product registered under section 3 of FIFRA. This registration is
listed below in Table 1.

                  Table 1.--Maneb Product Cancellation
------------------------------------------------------------------------
          EPA Registration Number                   Product Name
------------------------------------------------------------------------
019713-00377                                Maneb Technical
------------------------------------------------------------------------

    Table 2 below includes the name and address of record for the
registrant of the product listed in Table 1.

                Table 2.--Registrant of Canceled Product
------------------------------------------------------------------------
            EPA Company Number                Company Name and Address
------------------------------------------------------------------------
019713                                      Drexel Chemical Company
                                            1700 Channel Ave.
                                            P.O. Box 13327
                                            Memphis, TN 38113
------------------------------------------------------------------------

III. Summary of Public Comments Received and Agency Response to
Comments

    During the public comment period provided, EPA received no comments
in response to the January 6, 2010 notice announcing the Agency's
receipt of the request for voluntary cancellation of the product listed
in Table 1.

 IV. Cancellation Order

    Pursuant to FIFRA section 6(f), EPA hereby approves the requested
cancellation of the maneb registration identified in Table 1.
Accordingly, the Agency orders that the product registration identified
in Table 1 is hereby canceled. Any distribution, sale, or use of
existing stocks of the product identified in Table 1 in a manner
inconsistent with any of the Provisions for Disposition of Existing
Stocks set forth in Unit VI. will be considered a violation of FIFRA.

V. What is the Agency's Authority for Taking this Action?

    Section 6(f)(1) of FIFRA provides that a registrant of a pesticide
product may at any time request that any of its pesticide registrations
be canceled. FIFRA further provides that, before acting on the request,
EPA must publish a notice of receipt of any such request in the Federal
Register. Thereafter, following the public comment period, the
Administrator may approve such a request.

VI. Provisions for Disposition of Existing Stocks

    Existing stocks are those stocks of registered pesticide products
which are currently in the United States and which were packaged,
labeled, and released for shipment prior to the effective date of the
cancellation action. Due to a delay in the publication of the section
6(f)(1) notice, dated January 6, 2010, the date allowed to sell or
distribute existing stocks of the maneb technical will be changed from
February 10, 2010 (as stated in the section 6(f) receipt notice) to
until February 26, 2010. EPA is allowing sale, distribution and use in
the cancellation order as described below.
    1. The registrant will be allowed to sell or distribute existing
stocks of the maneb technical product identified in Table 1, until
February 26, 2010.
    2. The registrant will be allowed to use existing stocks to
formulate end-use products from the maneb technical product identified
in Table 1, until March 10, 2010.
    3. Persons other than the registrant may use the maneb end use
products until exhausted. Any use of existing stocks must be in a
manner consistent with the previously approved labeling for that
product.

List of Subjects

    Environmental protection, Pesticides and pests.

    Dated: February 18, 2010.
Richard P. Keigwin, Jr.
Director, Pesticide Re-evaluation Division, Office of Pesticide
Programs.

[FR Doc. 2010-3677 Filed 2-23-10; 8:45 am]
BILLING CODE 6560-50-S